Antibiotic susceptibility of Streptococcus pneumoniae in healthy carrier children in Murcia (Spain)

• Published in: Anales de pediatría (Barcelona, Spain : 2003) Vol. 83; no. 3; pp. 183 - 190
• Main Authors: Alfayate-Miguélez, S, Ruiz Gómez, J, Sanchez-Solis de Querol, M, Guerrero Gómez, C, Pérez Simón, M, Ortiz Romero, M M, Núñez Trigueros, M L, López Yepes, M L, Blazquez Abellán, A, Zarauz García, J M, Ruiz Merino, G, Ortuño del Moral, M P
• Format: Journal Article
• Language: Spanish
• Published: Spain 01-09-2015
• Subjects: Anti-Bacterial Agents - pharmacology; Carrier State; Child, Preschool; Cross-Sectional Studies; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Nose - microbiology; Pharynx - microbiology; Pneumococcal Infections; Prevalence; Serogroup; Spain; Streptococcus pneumoniae - classification; Streptococcus pneumoniae - drug effects; Streptococcus pneumoniae - isolation & purification; Antimicrobial sensitivity; Colonización nasofaríngea; Vacunas conjugadas; Conjugate vaccines; Nasopharyngeal carriage; Sensibilidad antibiótica; Streptococcus pneumoniae
• ISSN: 1695-9531
• DOI: 10.1016/j.anpedi.2014.10.003

Streptococcus pneumoniae (SP) is a human pathogen that involves a high use of antibiotics. The objective of the study was to determine the susceptibility to commonly used antibiotics and their associated risk factors, in order to promote rational use of antibiotics.
In A multicentre study was conducted in summer 2009 and winter 2010 on children attending paediatric clinics in the Region of Murcia. A nasopharyngeal sample was collected and an epidemiological questionnaire was completed. The study included 1562 children aged 1 and 4 years old.
Almost one-third (31.3%, 489/1562) of children were nasal carriers. A sensitivity study was carried out on 376 isolates, of which 343 were serotyped. Almost two-thirds (61.7%, 964/1562) of children had received at least one dose of PCV7 (heptavalent pneumococcal conjugate vaccine), and 12.8% (44/343) of the isolates belonged to PCV7 serotypes. The prevalence rates of penicillin resistance (meningitis infections criteria CMI>0.06mg/L) were 28.1%; however, this percentage was 54% in PCV7 serotypes. None of the isolates had (MIC >2mg/L), so prevalence rates of susceptibility with non-meningitis infections criteria were 100%. There was a high percentage of erythromycin resistance (45.7%). The factors favouring resistance to penicillin and cefotaxime were the consumption of antibiotics in the previous month and the carrying of vaccine serotypes. On the other hand, the age of 4 years old was a protective factor of resistance. The 14, 35B, 19A, 15A, and 19F serotypes were less susceptible to penicillin.
Both oral amoxicillin given to outpatients and intravenous penicillin or ampicillin to hospitalized patients are excellent options for the treatment of non-meningeal infections, as seen with pneumonia in these kinds of environments, where there is low incidence of isolates highly resistant to penicillin (CMI ≥ 2mg/L).